NASDAQ:CRGX CARGO Therapeutics (CRGX) Stock Price, News & Analysis $17.85 +0.15 (+0.85%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$17.57▼$19.7250-Day Range$14.60▼$21.0152-Week Range$13.14▼$33.92Volume120,541 shsAverage Volume237,464 shsMarket Capitalization$818.60 millionP/E RatioN/ADividend YieldN/APrice Target$30.83 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get CARGO Therapeutics alerts: Email Address CARGO Therapeutics MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside72.7% Upside$30.83 Price TargetShort InterestBearish12.18% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.62Based on 13 Articles This WeekInsider TradingAcquiring Shares$5 M Bought Last QuarterProj. Earnings GrowthDecreasingFrom ($4.59) to ($4.85) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.38 out of 5 starsMedical Sector751st out of 936 stocksBiological Products, Except Diagnostic Industry128th out of 154 stocks 3.5 Analyst's Opinion Consensus RatingCARGO Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageCARGO Therapeutics has only been the subject of 4 research reports in the past 90 days.Read more about CARGO Therapeutics' stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares Shorted12.18% of the float of CARGO Therapeutics has been sold short.Short Interest Ratio / Days to CoverCARGO Therapeutics has a short interest ratio ("days to cover") of 20.6, which indicates bearish sentiment.Change versus previous monthShort interest in CARGO Therapeutics has recently increased by 6.97%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCARGO Therapeutics does not currently pay a dividend.Dividend GrowthCARGO Therapeutics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRGX. Previous Next 2.0 News and Social Media Coverage News SentimentCARGO Therapeutics has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 13 news articles for CARGO Therapeutics this week, compared to 2 articles on an average week.MarketBeat FollowsOnly 1 people have added CARGO Therapeutics to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CARGO Therapeutics insiders have bought more of their company's stock than they have sold. Specifically, they have bought $4,998,000.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 1.38% of the stock of CARGO Therapeutics is held by insiders.Percentage Held by Institutions93.16% of the stock of CARGO Therapeutics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CARGO Therapeutics' insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for CARGO Therapeutics are expected to decrease in the coming year, from ($4.59) to ($4.85) per share.Price to Book Value per Share RatioCARGO Therapeutics has a P/B Ratio of 1.81. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about CARGO Therapeutics' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About CARGO Therapeutics Stock (NASDAQ:CRGX)CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.Read More CRGX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRGX Stock News HeadlinesJuly 24 at 5:39 AM | americanbankingnews.comBrokers Offer Predictions for CARGO Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:CRGX)July 24 at 4:30 AM | msn.comHC Wainwright & Co. Initiates Coverage of CARGO Therapeutics (CRGX) with Buy RecommendationJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 23 at 5:22 AM | americanbankingnews.comCARGO Therapeutics (NASDAQ:CRGX) Now Covered by Analysts at HC WainwrightJuly 22, 2024 | americanbankingnews.comCARGO Therapeutics (NASDAQ:CRGX) Shares Gap Up to $15.83July 20, 2024 | finance.yahoo.comAbivax SA (2X1.SG)June 4, 2024 | globenewswire.comCARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent DirectorMay 30, 2024 | investorplace.comUndiscovered Stocks on the Verge of a Breakout: 3 Names to Know NowJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.May 28, 2024 | marketwatch.comCargo Therapeutics Shares Drop 17% After Private Placement NewsMay 28, 2024 | globenewswire.comCARGO Therapeutics to Participate in Upcoming Investor ConferencesMay 28, 2024 | globenewswire.comCARGO Therapeutics Announces $110.0 Million Private Placement Equity FinancingMay 14, 2024 | markets.businessinsider.comCARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 14, 2024 | globenewswire.comCARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 9, 2024 | finance.yahoo.comIs There An Opportunity With CARGO Therapeutics, Inc.'s (NASDAQ:CRGX) 21% Undervaluation?April 18, 2024 | markets.businessinsider.comBuy Rating Affirmed for CARGO Therapeutics on Robust Trial Progress and Strong Market PotentialApril 18, 2024 | finance.yahoo.comCARGO Therapeutics, Inc. (CRGX)April 17, 2024 | investing.comCARGO Therapeutics appoints new board memberSee More Headlines Receive CRGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CARGO Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/26/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNASDAQ:CRGX Previous SymbolNASDAQ:CRGX CUSIPN/A CIK1966494 Webcargo-tx.com Phone650-379-6143FaxN/AEmployees116Year FoundedN/APrice Target and Rating Average Stock Price Target$30.83 High Stock Price Target$37.00 Low Stock Price Target$23.00 Potential Upside/Downside+72.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio16.78 Quick Ratio16.78 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$9.84 per share Price / Book1.81Miscellaneous Outstanding Shares45,860,000Free Float45,229,000Market Cap$818.60 million OptionableN/A BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMs. Gina Chapman (Age 56)President, CEO & Director Comp: $755.35kDr. Crystal L. Mackall M.D. (Age 63)Co-Founder Comp: $160kDr. Shishir Gadam Ph.D. (Age 57)Chief Technical Officer Comp: $674.03kDr. Robbie Majzner M.D.Founder & Chair of Scientific Advisory BoardMs. Nancy Goodman J.D.FounderDr. Louai LabaniehFounderMr. Anup Radhakrishnan (Age 44)CFO, Secretary & Chief Business Officer Dr. Corinne D. Epperly M.D. (Age 46)M.P.H., Chief Operating Officer Mr. Faisal Shawwa M.B.A.Senior Vice President of Finance & AccountingDr. Michael Ports Ph.D. (Age 43)Chief Scientific Officer More ExecutivesKey CompetitorsADMA BiologicsNASDAQ:ADMAApogee TherapeuticsNASDAQ:APGESpringWorks TherapeuticsNASDAQ:SWTXKymera TherapeuticsNASDAQ:KYMRBeam TherapeuticsNASDAQ:BEAMView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 7,146 shares on 7/26/2024Ownership: 0.151%Samsara Biocapital Gp, LlcBought 294,000 shares on 5/30/2024Total: $5.00 M ($17.00/share)Janus Henderson Group PLCSold 43,151 shares on 5/16/2024Ownership: 6.755%California State Teachers Retirement SystemBought 15,115 shares on 5/16/2024Ownership: 0.038%Price T Rowe Associates Inc. MDBought 854,840 shares on 5/15/2024Ownership: 7.857%View All Insider TransactionsView All Institutional Transactions CRGX Stock Analysis - Frequently Asked Questions How have CRGX shares performed this year? CARGO Therapeutics' stock was trading at $23.15 at the beginning of the year. Since then, CRGX stock has decreased by 22.9% and is now trading at $17.85. View the best growth stocks for 2024 here. How were CARGO Therapeutics' earnings last quarter? CARGO Therapeutics, Inc. (NASDAQ:CRGX) released its quarterly earnings results on Tuesday, May, 14th. The company reported ($0.87) earnings per share for the quarter, topping the consensus estimate of ($1.05) by $0.18. When did CARGO Therapeutics IPO? CARGO Therapeutics (CRGX) raised $281 million in an IPO on Friday, November 10th 2023. The company issued 18,750,000 shares at a price of $15.00 per share. Who are CARGO Therapeutics' major shareholders? CARGO Therapeutics' top institutional shareholders include Bank of New York Mellon Corp (0.15%). Insiders that own company stock include Samsara Biocapital Gp, Llc and Perceptive Advisors Llc. View institutional ownership trends. How do I buy shares of CARGO Therapeutics? Shares of CRGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CRGX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CARGO Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CARGO Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
